Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 221: In C-reactive protein (CRP), the 'C' stands for which of the following?

A. Canavallin A
B. Cellular
C. Chondroitin sulfate
D. C polysaccharide of Streptococcus (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. C polysaccharide of Streptococcus** **Why it is correct:** C-reactive protein (CRP) was first discovered in 1930 by Tillet and Francis. It was named so because of its unique ability to precipitate the **C-polysaccharide (a somatic antigen) of *Streptococcus pneumoniae*** in the presence of calcium. It is a classic acute-phase reactant synthesized by the liver in response to interleukin-6 (IL-6). **Analysis of Incorrect Options:** * **A. Canavallin A:** This is a lectin (carbohydrate-binding protein) derived from the jack bean. It is used in research to study cell surface glycoproteins but has no relation to the naming of CRP. * **B. Cellular:** While CRP is part of the innate immune response, the 'C' does not stand for cellular. CRP is a secreted plasma protein, not a cellular component. * **C. Chondroitin sulfate:** This is a glycosaminoglycan found in connective tissues and cartilage. It does not react with CRP. **High-Yield Clinical Pearls for NEET-PG:** * **Structure:** CRP is a member of the **pentraxin** family, consisting of five identical non-covalently bound subunits. * **Function:** It acts as an **opsonin**, activating the classical complement pathway by binding to phosphocholine expressed on the surface of dead cells and bacteria. * **Clinical Marker:** It is a non-specific marker of inflammation. **hs-CRP (high-sensitivity CRP)** is specifically used as a biomarker to assess the risk of cardiovascular disease (Atherosclerosis). * **Kinetics:** CRP levels rise rapidly (within 6–12 hours) and have a short half-life (19 hours), making it an excellent marker for monitoring disease activity and response to treatment.

Question 222: Alcohol/ethanol induced fatty liver is caused by an increased ratio of?

A. NAD+ to NADH
B. NADH to NAD+ (Correct Answer)
C. NADPH to NADP+
D. NADP+ to NADPH

Explanation: **Explanation:** The metabolism of ethanol in the liver occurs via two major oxidative steps. First, **Alcohol Dehydrogenase (ADH)** converts ethanol to acetaldehyde. Second, **Acetaldehyde Dehydrogenase (ALDH)** converts acetaldehyde to acetate. Both reactions require **NAD+** as a cofactor and reduce it to **NADH**. **Why Option B is Correct:** Excessive alcohol consumption leads to an overproduction of NADH, significantly increasing the **NADH:NAD+ ratio**. This high ratio shifts the metabolic equilibrium of the liver: 1. **Inhibition of Gluconeogenesis:** High NADH favors the conversion of pyruvate to lactate, leading to fasting hypoglycemia and lactic acidosis. 2. **Inhibition of Fatty Acid Oxidation:** High NADH signals "energy surplus," inhibiting β-oxidation of fatty acids. 3. **Stimulation of Lipogenesis:** The excess NADH promotes the conversion of Dihydroxyacetone phosphate (DHAP) to Glycerol-3-phosphate, providing the backbone for Triglyceride synthesis. This combination of decreased oxidation and increased synthesis leads to **Steatosis (Fatty Liver)**. **Why Other Options are Incorrect:** * **Option A:** An increased NAD+ to NADH ratio occurs during states of energy depletion (e.g., exercise or fasting) and would actually promote fatty acid oxidation, not fatty liver. * **Options C & D:** While NADPH is involved in reductive biosynthesis (like fatty acid synthesis), the primary metabolic hallmark of ethanol toxicity is the alteration of the **NAD+/NADH** redox state in the cytosol and mitochondria, not the pentose phosphate pathway cofactors (NADP+/NADPH). **Clinical Pearls for NEET-PG:** * **Mallory-Denk Bodies:** Eosinophilic cytoplasmic inclusions (cytokeratin filaments) seen in alcoholic hepatitis. * **AST > ALT:** In alcoholic liver disease, the AST:ALT ratio is typically **>2:1** (Alcoholic **S**tatistically **T**all). * **Disulfiram:** Inhibits ALDH, causing acetaldehyde accumulation, leading to nausea and flushing (Disulfiram-like reaction).

Question 223: Which enzymes are normally found in cerebrospinal fluid?

A. GGT and ALP
B. ALP and CK-MB
C. CK and LDH (Correct Answer)
D. Deaminase and peroxidase

Explanation: **Explanation:** The presence of enzymes in the cerebrospinal fluid (CSF) is a result of local synthesis within the central nervous system (CNS) or release from damaged neural tissue. Under normal physiological conditions, the blood-brain barrier (BBB) is impermeable to large protein molecules, meaning most serum enzymes do not cross into the CSF. **Why Option C is Correct:** * **Creatine Kinase (CK):** Specifically the **CK-BB** isoenzyme is found in high concentrations in brain tissue. Small amounts are normally present in the CSF due to normal cellular turnover. * **Lactate Dehydrogenase (LDH):** This enzyme is involved in anaerobic glycolysis. Normal CSF contains low levels of LDH (derived from brain parenchyma and some diffusion). * **Clinical Significance:** Elevated CSF-LDH is a marker for bacterial meningitis or CNS malignancy, while elevated CSF-CK is seen after strokes, seizures, or head trauma. **Analysis of Incorrect Options:** * **Option A & B (ALP & GGT):** Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT) are primarily markers of hepatobiliary and bone metabolism. They are large molecules that do not cross the intact BBB and are not significantly synthesized in the brain. **CK-MB** is specific to cardiac muscle and is not a normal constituent of CSF. * **Option D (Deaminase & Peroxidase):** While Adenosine Deaminase (ADA) is a crucial marker for **Tubercular Meningitis**, it is not considered a "normal" constituent in significant measurable quantities in healthy CSF. Peroxidases are primarily associated with inflammatory cells (like neutrophils) and are absent in normal, acellular CSF. **High-Yield Clinical Pearls for NEET-PG:** * **ADA in CSF:** If >10 U/L, it is highly suggestive of **Tubercular Meningitis**. * **LDH Isoenzymes:** LDH-4 and LDH-5 are elevated in bacterial meningitis (due to granulocytes), while LDH-1 and LDH-2 are elevated in viral meningitis. * **Normal CSF Protein:** 15–45 mg/dL (much lower than plasma protein levels).

Question 224: Which of the following is NOT a cause of unconjugated hyperbilirubinemia?

A. Hemolytic anemia
B. Large hematoma
C. Rotor syndrome (Correct Answer)
D. Megaloblastic anemia

Explanation: ### Explanation Hyperbilirubinemia is classified into **unconjugated (indirect)** and **conjugated (direct)** based on whether the pathology occurs before or after the liver conjugates bilirubin with glucuronic acid. **Why Rotor Syndrome is the Correct Answer:** Rotor syndrome is a rare, autosomal recessive disorder characterized by **conjugated hyperbilirubinemia**. It results from a defect in the hepatic storage and re-uptake of conjugated bilirubin (specifically involving OATP1B1 and OATP1B3 transporters). Unlike unconjugated causes, the liver successfully conjugates the bilirubin, but it cannot be properly stored or excreted into the bile, leading to its regurgitation into the blood. **Analysis of Incorrect Options (Causes of Unconjugated Hyperbilirubinemia):** * **Hemolytic Anemia:** Increased breakdown of RBCs leads to an overproduction of heme, overwhelming the liver's conjugating capacity. * **Large Hematoma:** As a large blood clot resolves, the breakdown of hemoglobin releases massive amounts of bilirubin, leading to resorptive jaundice (unconjugated). * **Megaloblastic Anemia:** This causes **ineffective erythropoiesis**, where RBC precursors are destroyed within the bone marrow before maturation. This "intramedullary hemolysis" releases significant unconjugated bilirubin. **High-Yield Clinical Pearls for NEET-PG:** * **Rotor vs. Dubin-Johnson:** Both cause conjugated hyperbilirubinemia. However, in **Dubin-Johnson**, the liver is **black/pigmented** (due to melanin-like pigment) and there is a defect in the MRP2 transporter. In **Rotor syndrome**, the liver has **normal morphology**. * **Crigler-Najjar & Gilbert Syndrome:** These are the classic genetic causes of **unconjugated** hyperbilirubinemia due to deficiency/absence of the enzyme UDP-glucuronosyltransferase (UGT1A1). * **Urine Findings:** Unconjugated bilirubin is water-insoluble and bound to albumin; therefore, it **never** appears in urine (acholuric jaundice). Conjugated bilirubin is water-soluble and appears in urine (dark urine).

Question 225: A patient presents with jaundice and white stools. Which of the following enzymes is typically not elevated in this clinical scenario?

A. 5' nucleotidase
B. Alkaline phosphatase
C. Glutamate reductase (Correct Answer)
D. Gamma glutamyl transpeptidase

Explanation: **Explanation:** The clinical presentation of **jaundice and white (acholic) stools** is a classic indicator of **Obstructive Jaundice** (Post-hepatic or Cholestatic jaundice). In this condition, bile flow is obstructed, preventing bilirubin from reaching the intestine (causing white stools) and leading to the regurgitation of bile components into the blood. **1. Why Glutamate Reductase is the Correct Answer:** Glutamate reductase (often confused with Glutamate Dehydrogenase or Glutathione Reductase in exams) is not a standard marker for hepatobiliary disease. In the context of liver function tests, the enzymes that rise significantly during obstruction are those associated with the **biliary canalicular membrane**. Glutamate-related enzymes are typically intracellular and rise in hepatocellular necrosis (like hepatitis), but they are not specific markers for cholestasis. **2. Analysis of Incorrect Options (Markers of Cholestasis):** * **Alkaline Phosphatase (ALP):** This is the hallmark enzyme for obstruction. It is synthesized by canalicular cells; when bile salts accumulate due to obstruction, they act as detergents to release ALP into the serum. * **5' Nucleotidase:** This enzyme is highly specific for the liver. It is elevated in obstructive jaundice and is used to confirm that a raised ALP is of hepatic origin rather than bone origin. * **Gamma-Glutamyl Transpeptidase (GGT):** A sensitive marker for biliary tree damage and induction by alcohol/drugs. Like ALP and 5' nucleotidase, it rises significantly in obstructive scenarios. **Clinical Pearls for NEET-PG:** * **The "Cholestatic Pattern":** Disproportionate rise in ALP, GGT, and 5' Nucleotidase compared to ALT/AST. * **GGT vs. ALP:** If ALP is high but GGT is normal, suspect **bone disease**. If both are high, suspect **liver/biliary disease**. * **White Stools:** Pathognomonic for the absence of stercobilin in the gut, usually due to gallstones or head of pancreas carcinoma.

Question 226: Which of the following is used for testing absorption in the intestine?

A. Xylose (Correct Answer)
B. Sucrose
C. Fructose
D. Maltose

Explanation: **Explanation:** The **D-Xylose absorption test** is a classic clinical tool used to differentiate between **malabsorption** (mucosal disease) and **maldigestion** (pancreatic insufficiency). **Why Xylose is correct:** D-Xylose is an eight-carbon aldopentose that is absorbed via passive diffusion in the proximal small intestine. Unlike other sugars, it does not require pancreatic enzymes (like amylase) or bile salts for digestion. Once absorbed, it is not metabolized by the liver and is excreted unchanged in the urine. Therefore, low levels of xylose in the blood or urine after oral administration indicate a **mucosal defect** in the small intestine (e.g., Celiac disease, Tropical sprue, or Whipple’s disease). **Why the other options are incorrect:** * **Sucrose, Maltose, and Fructose:** These are common dietary sugars. Sucrose and Maltose are disaccharides that require specific brush-border enzymes (**Sucrase** and **Maltase**) for breakdown into monosaccharides before absorption. Fructose is a monosaccharide but is absorbed via facilitated diffusion (GLUT-5). Because these sugars are rapidly metabolized by the body for energy, they cannot be used as reliable markers to quantify intestinal absorptive capacity in a standardized test. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Test Result:** High urinary excretion of xylose (>4g in 5 hours) suggests the intestinal mucosa is intact, pointing toward **Pancreatic Insufficiency** as the cause of steatorrhea. * **Abnormal Test Result:** Low urinary excretion suggests **Intestinal Mucosal Disease**. * **False Positives:** Low urinary xylose can occur in patients with **renal dysfunction**, ascites, or Small Intestinal Bacterial Overgrowth (SIBO), as bacteria may metabolize the xylose before it is absorbed.

Question 227: Glycosylated hemoglobin reflects the mean blood glucose level of the previous?

A. 15 days
B. 1 month
C. 3 months (Correct Answer)
D. 6 months

Explanation: **Explanation:** **1. Why 3 months is correct:** Glycosylated hemoglobin (HbA1c) is formed by the **non-enzymatic glycation** of the N-terminal valine of the beta chain of hemoglobin. This process is irreversible and occurs at a rate proportional to the blood glucose concentration. Because hemoglobin resides within red blood cells (RBCs), the HbA1c level reflects the average glucose concentration over the **lifespan of the RBC**, which is approximately **120 days (roughly 3–4 months)**. However, because newer RBCs contribute more to the total hemoglobin pool than older ones, the value most accurately reflects the preceding **8–12 weeks**. **2. Why other options are incorrect:** * **15 days:** This is too short. While 15-day trends can be measured by **Fructosamine** (glycosylated albumin), which has a half-life of ~2-3 weeks, HbA1c remains stable for much longer. * **1 month:** This only captures the most recent portion of the RBC lifespan and does not represent the full diagnostic window of HbA1c. * **6 months:** This exceeds the average 120-day survival of an erythrocyte; by 6 months, the original population of RBCs has been replaced. **3. High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Cut-off:** According to ADA criteria, HbA1c **≥ 6.5%** is diagnostic for Diabetes Mellitus. * **Falsely Low HbA1c:** Seen in conditions with increased RBC turnover (e.g., Hemolytic anemia, recent blood transfusion, or pregnancy). * **Falsely High HbA1c:** Seen in conditions that prolong RBC lifespan (e.g., Vitamin B12 or Folate deficiency anemia) or Splenectomy. * **Formula:** Estimated Average Glucose (eAG) in mg/dL = $(28.7 \times HbA1c) - 46.7$.

Question 228: What is the minimum level of TSH that can be detected by third-generation TSH assays?

A. 0.4 IU/ml
B. 0.04 IU/ml (Correct Answer)
C. 0.004 IU/ml
D. 4 IU/ml

Explanation: ### Explanation **Concept Overview:** Thyroid Stimulating Hormone (TSH) assays are categorized into "generations" based on their **Functional Sensitivity**—the lowest concentration of TSH that can be measured with a coefficient of variation (CV) of less than 20%. This sensitivity is crucial for distinguishing between suppressed TSH levels (as seen in hyperthyroidism) and truly undetectable levels. **Why Option B is Correct:** * **Third-generation assays** (typically chemiluminometric assays) have a functional sensitivity of **0.01 to 0.02 mIU/L**. * In the context of standard medical examinations like NEET-PG, the value **0.01–0.05 mIU/L** (or **0.04 IU/ml** as per the option) is the recognized threshold. These assays are sensitive enough to distinguish between "low" and "suppressed" TSH, which is vital for diagnosing subclinical hyperthyroidism. **Analysis of Incorrect Options:** * **Option A (0.4 IU/ml):** This represents the lower limit of the **normal reference range** for TSH in healthy individuals, not the detection limit of the assay itself. * **Option C (0.004 IU/ml):** This level of sensitivity (0.001–0.005) corresponds to **Fourth-generation assays**, which are primarily used in research settings and are not yet the standard clinical benchmark. * **Option D (4 IU/ml):** This is a high value often seen in primary hypothyroidism; it is well within the detection range of even the most primitive assays. **High-Yield Clinical Pearls for NEET-PG:** * **1st Generation:** Sensitivity ~1.0 mIU/L (Can only diagnose hypothyroidism). * **2nd Generation:** Sensitivity ~0.1 mIU/L (Radioimmunoassay/RIA). * **3rd Generation:** Sensitivity **0.01 mIU/L** (Current clinical gold standard). * **Clinical Utility:** Third-generation assays are essential to differentiate **Graves' disease** (TSH <0.01) from other conditions where TSH might be low but detectable. * **Note on Units:** In most clinical literature, mIU/L and µIU/ml are used interchangeably.

Question 229: What is used to assess the long-term control of diabetes?

A. Random blood sugar
B. Microalbuminuria/creatinine ratio
C. HbA2
D. HbA1c (Correct Answer)

Explanation: **Explanation:** **HbA1c (Glycated Hemoglobin)** is the gold standard for assessing long-term glycemic control. It is formed by the non-enzymatic, irreversible attachment of glucose to the N-terminal valine of the beta chain of hemoglobin (Glycation). Since the average lifespan of a Red Blood Cell (RBC) is **120 days**, the HbA1c level reflects the average blood glucose concentration over the preceding **2–3 months**. **Analysis of Incorrect Options:** * **A. Random Blood Sugar:** This provides a "snapshot" of the blood glucose at a single point in time. It is influenced by recent meals or physical activity and cannot reflect long-term control. * **B. Microalbuminuria/creatinine ratio:** This is a screening tool for **Diabetic Nephropathy** (early kidney damage), not a measure of glycemic control. * **C. HbA2:** This is a minor variant of adult hemoglobin ($\alpha_2\delta_2$). Elevated levels are diagnostic for **Beta-thalassemia trait**, having no clinical relevance to diabetes monitoring. **High-Yield Clinical Pearls for NEET-PG:** * **Target Level:** For most diabetic patients, the goal is an HbA1c **< 7%**. * **Fructosamine Test:** Measures glycated albumin and reflects glucose control over the past **2–3 weeks**. It is used when HbA1c is unreliable (e.g., Hemolytic anemia, Pregnancy, or Sickle cell disease). * **False Low HbA1c:** Seen in conditions that decrease RBC lifespan (Hemolysis, recent blood transfusion, or Erythropoietin therapy). * **False High HbA1c:** Seen in Iron deficiency anemia (due to increased RBC lifespan).

Question 230: Which myocardial isozyme of CK is specific for myocardial infarction?

A. CK-BB
B. CK-MB (Correct Answer)
C. CK-MM
D. All of the above

Explanation: **Explanation:** Creatine Kinase (CK) is a dimeric enzyme composed of two subunits: **M (Muscle)** and **B (Brain)**. These subunits combine to form three distinct isoenzymes, each with specific tissue distributions. **Why CK-MB is the Correct Answer:** **CK-MB (MB variant)** is primarily found in the **myocardium** (cardiac muscle). While a small amount exists in skeletal muscle, it makes up about 15-40% of the total CK in the heart. Following a Myocardial Infarction (MI), damaged cardiac myocytes leak CK-MB into the bloodstream. It typically rises within 4–6 hours, peaks at 12–24 hours, and returns to baseline within 48–72 hours. Its rapid clearance makes it particularly useful for detecting **re-infarction**. **Analysis of Incorrect Options:** * **CK-BB (Option A):** Found predominantly in the **Brain** and smooth muscle (e.g., lungs, bladder). It is rarely elevated in serum because it does not cross the blood-brain barrier easily. * **CK-MM (Option B):** Found primarily in **Skeletal Muscle** (99%) and the heart (60-80%). Elevations are seen in muscular dystrophy, strenuous exercise, or trauma, making it non-specific for cardiac injury. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** While CK-MB is the specific *isozyme* of CK, **Cardiac Troponins (I and T)** are currently the overall "Gold Standard" biomarkers for MI due to higher sensitivity and specificity. * **CK-MB Index:** If the CK-MB/Total CK ratio is **>5%**, it strongly suggests myocardial origin rather than skeletal muscle damage. * **Macro-CK:** An atypical form of CK (CK bound to IgG) that can cause a false elevation in total CK levels.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free